Lucid Diagnostics Inc. — Director's Dealing 2022

Jun 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2022-06-07

Reporting Person: Gordon Michael Adam (General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-07	Employee stock option (right to buy)	$1.93	A	200000	Acquired	2032-06-07	Common stock (200000)	Direct

Footnotes

F1: The option vests in 12 quarterly installments, with first installment vesting June 30, 2022.